# 0574-4022-35 · Bacitracin Ophthalmic Ointment · Padagis US LLC — FDA drug shortage duration tracker For 0574-4022-35 · Bacitracin Ophthalmic Ointment · Padagis US LLC, package ndc is 0574-4022-35; generic name is Bacitracin Ophthalmic Ointment; manufacturer is Padagis US LLC; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01. - **Package NDC:** 0574-4022-35 _(verified: appears in the quote below)_ - **Generic name:** Bacitracin Ophthalmic Ointment _(verified: appears in the quote below)_ - **Manufacturer:** Padagis US LLC _(verified: appears in its own passage below)_ - **Status:** Current _(verified: appears in its own passage below)_ - **Availability now:** Unavailable _(verified: appears in the quote below)_ - **FDA note:** Shortage is estimated for 24 months _(verified: appears in the quote below)_ - **Initial posting date:** 03/03/2025 _(verified: appears in the quote below)_ - **Last update date:** 06/01/2026 _(verified: appears in its own passage below)_ - **Days in shortage:** 547 _(our reading, not quoted from the source)_ - **Reason for shortage:** Discontinuation of the manufacture of the drug _(verified: appears in its own passage below)_ - **Dosage form:** Ophthalmic Ointment _(verified: appears in its own passage below)_ - **Therapeutic category:** Anti-Infective _(verified: appears in its own passage below)_ ## What the source says > "initial_posting_date": "03/03/2025", "package_ndc": "0574-4022-35", "generic_name": "Bacitracin Ophthalmic Ointment", "contact_info": "866-634-9120", "availability": "Unavailable", "related_info": "Shortage is estimated for 24 months" ## Where each value comes from This source states these in separate places, so each value is shown with the passage that states it. ### Manufacturer > "update_date": "06/01/2026", "therapeutic_category": [ "Anti-Infective", "Ophthalmology" ], "dosage_form": "Ophthalmic Ointment", "presentation": "Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)", "company_name": "Padagis US LLC", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current" ### Status > "update_date": "06/01/2026", "therapeutic_category": [ "Anti-Infective", "Ophthalmology" ], "dosage_form": "Ophthalmic Ointment", "presentation": "Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)", "company_name": "Padagis US LLC", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current" ### Last update date > "update_date": "06/01/2026", "therapeutic_category": [ "Anti-Infective", "Ophthalmology" ], "dosage_form": "Ophthalmic Ointment", "presentation": "Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)", "company_name": "Padagis US LLC", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current" ### Reason for shortage > "update_date": "06/01/2026", "therapeutic_category": [ "Anti-Infective", "Ophthalmology" ], "dosage_form": "Ophthalmic Ointment", "presentation": "Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)", "company_name": "Padagis US LLC", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current" ### Dosage form > "update_date": "06/01/2026", "therapeutic_category": [ "Anti-Infective", "Ophthalmology" ], "dosage_form": "Ophthalmic Ointment", "presentation": "Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)", "company_name": "Padagis US LLC", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current" ### Therapeutic category > "update_date": "06/01/2026", "therapeutic_category": [ "Anti-Infective", "Ophthalmology" ], "dosage_form": "Ophthalmic Ointment", "presentation": "Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)", "company_name": "Padagis US LLC", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current" ## Source - https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Padagis%20US%20LLC%22+AND+generic_name%3A%22Bacitracin%20Ophthalmic%20Ointment%22+AND+status%3A%22Current%22&limit=1000 Last verified: 2026-09-01. Review by: 2026-09-04. Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).